Skip to main content
Signal8
Thompson Elizabeth H.Z. profile photo

Elizabeth H.z. Thompson

CIK: 0001861477

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (21.4%)

Position reduction

Option Exercises (M)2 (14.3%)

Derivative conversions

Awards (A)8 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)1 (7.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ACADIA PHARMACEUTICALS INC logo
ACAD

ACADIA PHARMACEUTICALS INC

Officer
IGM Biosciences, Inc. logo
IGMS

IGM Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • ACADIA PHARMACEUTICALS INC logo
    ACAD

    ACADIA PHARMACEUTICALS INC

    Jul 30, 2026
    Sale(S)
    Direct
    50 shares at avg. $26.17$1K
  • ACADIA PHARMACEUTICALS INC logo
    ACAD

    ACADIA PHARMACEUTICALS INC

    Jul 30, 2026
    Sale(S)
    Direct
    16.5K shares at avg. $26.13$431K
  • ACADIA PHARMACEUTICALS INC logo
    ACAD

    ACADIA PHARMACEUTICALS INC

    Jul 29, 2026
    Exercise(M)
    Direct
    32.3K shares-
  • ACADIA PHARMACEUTICALS INC logo
    ACAD

    ACADIA PHARMACEUTICALS INC

    Mar 25, 2026
    Sale(S)
    Direct
    3.4K shares at avg. $21.47$74K
  • ACADIA PHARMACEUTICALS INC logo
    ACAD

    ACADIA PHARMACEUTICALS INC

    Mar 24, 2026
    Exercise(M)
    Direct
    6.7K shares-
  • ACADIA PHARMACEUTICALS INC logo
    ACAD

    ACADIA PHARMACEUTICALS INC

    Mar 6, 2026
    Award(A)

    Restricted Stock Units

    Direct
    29.5K shares-
  • ACADIA PHARMACEUTICALS INC logo
    ACAD

    ACADIA PHARMACEUTICALS INC

    Mar 6, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    101.6K shares-
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Aug 14, 2025
    Disposition(D)
    Direct
    7.2K shares-
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Jun 30, 2025
    Award(A)
    Direct
    694 shares-
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Mar 31, 2025
    Award(A)
    Direct
    694 shares-
  • ACADIA PHARMACEUTICALS INC logo
    ACAD

    ACADIA PHARMACEUTICALS INC

    Mar 24, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    91.4K shares-
  • ACADIA PHARMACEUTICALS INC logo
    ACAD

    ACADIA PHARMACEUTICALS INC

    Mar 24, 2025
    Award(A)

    Restricted Stock Units

    Direct
    26.9K shares-
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Dec 31, 2024
    Award(A)
    Direct
    1.5K shares-
  • IGM Biosciences, Inc. logo
    IGMS

    IGM Biosciences, Inc.

    Sep 30, 2024
    Award(A)
    Direct
    1.5K shares-

1-14 of 14

About Thompson Elizabeth H.Z.

Thompson Elizabeth H.Z. (SEC CIK 0001861477) files insider reports with the SEC as EVP, Head of Research & Dev of ACADIA PHARMACEUTICALS INC (ACAD) and Director of IGM Biosciences, Inc. (IGMS).

Signal8 holds 9 ownership filings by Thompson Elizabeth H.Z., all Form 4s, filed between Oct 2, 2024 and Jul 31, 2026. Those filings report 14 transactions, from Sep 30, 2024 to Jul 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Thompson Elizabeth H.Z.'s filings is in SAN DIEGO, CA.

Recent filings by Thompson Elizabeth H.Z.

  • Jul 30, 2026: Open-market sales of ACAD shares (2 lines, Form 4, code S).
  • Jul 29, 2026: Option exercise of ACAD shares (Form 4, code M).
  • Mar 25, 2026: Open-market sale of ACAD shares (Form 4, code S).
  • Mar 24, 2026: Option exercise of ACAD shares (Form 4, code M).
  • Mar 6, 2026: Grants or awards of ACAD derivative securities (2 lines, Form 4, code A).

Other insiders filing for ACADIA PHARMACEUTICALS INC (ACAD)

How to read Form 4 transaction codes